2024

Economics of primary healthcare: cost estimation of clinical services at primary care facilities in the six countries of the Gulf Cooperation Council

Khalifa Elmusharaf, Sébastien Poix, Daniel Grafton, Johanna S Jung, Rebecca Gribble, Rachael Stanton, Lamia Mahmoud, Deena Hamza Al Asfoor, Tayba Alawadi, Mohammed Mustafa, Lulwa Shuwaiter, Mohammed S Alsuwaidan, Zahir Al-Abri, Sultana Al-Sabahi, Sherif Fadda, Hassan Raza Syed, Muneera Almutairi, Yahya M Al-Farsi, Nicholas Banatvala, Dudley Tarlton

The reported impact of non-communicable disease investment cases in 13 countries

Troisi G, Small R, Chestnov R, Andreasyan D, Khachatryan H, Phillips EA, Malcolm T, Kol H, Khodjaeva N, Gebremichael M, Tessema AW, Workneh AB, Davidson T,  Harris M, Ibraeva N, Nurmatova A, Altymysheva A, Go JJ, Kontsevaya A, Hanbunjerd K, Bunluesin S, Nieveras O, Ekinci B, Keskinkiliç B, Erguder T, Akiya OC, Kasule H, Nakanjako A, Shukurov S, Kasymova N, Banda P, Kakoma E, Bakyaita NN,  Kulikov A, Tarlton D, Putoud N, Chiossi S, Webb D, Banatvala N. BMJ Global Health 2024;9:e014784. 

Advancing progress on tobacco control in low-income and middle-income countries through economic analysis 

Roy Small, Rachel Nugent, Douglas Webb, Brian Hutchinson, Garrison Spencer, Carrie Ngongo, Roman Chestnov, Dudley Tarlton; Tobacco Control May 2024, 33 (Suppl 1) s3-s9; DOI: 10.1136/tc-2023-058335

Interpreting results, impacts and implications from WHO FCTC tobacco control investment cases in 21 low-income and middle-income countries

Nathan Mann, Garrison Spencer, Brian Hutchinson, Carrie Ngongo, Dudley Tarlton, Douglas Webb, Daniel Grafton, Rachel Nugent; Tobacco Control May 2024, 33 (Suppl 1) s17-s26; DOI: 10.1136/tc-2023-058337

Equity implications of tobacco taxation: results from WHO FCTC investment cases

Garrison Spencer, Rachel Nugent, Nathan Mann, Brian Hutchinson, Carrie Ngongo, Dudley Tarlton, Roy Small, Douglas Webb; Tobacco Control May 2024, 33 (Suppl 1) s27-s33; DOI: 10.1136/tc-2023-058338

Evolving methodology of national tobacco control investment cases

Rachel Nugent, Brian Hutchinson, Nathan Mann, Carrie Ngongo, Garrison Spencer, Daniel Grafton, Roy Small; Tobacco Control May 2024, 33 (Suppl 1) s10-s16; DOI: 10.1136/tc-2023-058336

2023

The promise of digital health technologies for integrated care for maternal and child health and non-communicable diseases

Collins TE, Akselrod S, Altymysheva A, Nga PTQ, Banatvala N, Berlina D. BMJ 2023.381:e071074.

Cross-country analysis of national mental health investment case studies in sub-Saharan Africa and Central, South and South-East Asia

Chisholm D, Lee YY, Baral PP, Bhagwat S, Dombrovskiy V, Grafton D, Kontsevaya A, Huque R, Kalani Okware K, Kulikov A, Marahatta K, Mavunganidze P, Omar N, Prasai D, Putoud N, Tsoyi E, Vergara J. Front. Health Serv. 2023 3:1214885.

Noncommunicable diseases: a compendium

Eds: Nick Banatvala, Pascal Bovet.2023. Routledge, Oxford UK.

2022

Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases

Suzuki M, Webb D, Small R. Int J Health Policy Manag. 2022;11:1078–1089.

Competing Values in Global Health: Is Inclusive Governance Valued Higher Than the Right to Health? A Response to the Recent Commentaries

Suzuki M, Small R, Webb D. Int J Health Policy Manag. 2022;11:1233-1235.

The case for investing in the prevention and control of non-communicable diseases in the six countries of the Gulf Cooperation Council: an economic evaluation

Elmusharaf K, Grafton D, Jung JS, Roberts E, Yahya Al-Farsi Y, Ameera Ali Al Nooh A, Buthaina Bin Belaila B, Amin ElShamy A, Hamoud Al-Zuabi H, Ateeq Al Mutawa K, Alraisi S, Al Lawat N, Gharbal A,Alomary S, Kulikov A, Pourghazian N, Slama S, Tarlton D, Banatvala N. BMJ Global Health 2022;7:e008670.

The case for investment in tobacco control: lessons from four countries in the Americas

Hutchinson B, Brispat F, Calderón Pinzón LV, Sarmiento A, Solís E, Nugent R, Mann N, Spencer G,  Ngongo C, Black A, Audera-Lopez MC, Ntiabang TA, Tarlton D, Cooke J, Small R, Roche M, Sandoval RC. Rev Panam Salud Publica. 2022;46:e174.

2021

Addressing the double burden of the COVID-19 and noncommunicable disease pandemics: a new global governance challenge 

Collins T, Tello J, Van Hilten M, Mahy L, Banatvala N, Fones G, Akselrod S, Bull, F, Cieza A, Farrington J, Fisher J, Gonzalez, C, Guerra J, Hanna F, Jakab Z, Kulikov A, Saeed, K, Abdel Latif N, Mikkelsen B, Pourghazian N, Troisi G, Willumsen J. Intern J Health Governance 2021:26;199-212.

2020

Responding to non-communicable diseases during and beyond the covid-19 pandemic

Banatvala N, Small R. BMJ Opinion. 11 September 2020.

Non-communicable diseases among adolescents: current status, determinants, interventions and policies.

Akseer N, Mehta S, Wigle J, Chera R, Brickman ZJ, Al-Gashm S, Sorichetti B, Vandermorris A, Hipgrave DB, Schwalbe N, Bhutta ZA. Non-communicable diseases among adolescents: current status, determinants, interventions and policies. BMC public health. 2020.

2019

Time to align: development cooperation for the prevention and control of non-communicable diseases

Collins T, Nugent R, Webb D, Placella E, Evans T, Akinnawo A. BMJ. 2019:366:I4499.

Prioritising action on alcohol for health and development

Rekve D, Banatvala N, Karpati A, Tarlton D, Westerman L, Sperkova K, Casswell S, Duennbier M, Rojhani A, Bakke Ø, Monteiro M, Linou N, Kulikov A, Poznyak VB.  BMJ 2019;367:l6162.

The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions

Hutchinson B, Small R, Acquah K, Sandoval R, Nugent R, Belausteguigoitia DI, Banatvala N, Webb D, Tarlton D, Kulikov A, Prieto E, Santi K. PLoS ONE 2019. 14 (10): e0223412. 

Using economic evidence to support policy decisions to fund interventions for non-communicable diseases

Bertram M, Banatvala N, Kulikov A, Belausteguigoitia I, Sandoval R, Hennis A, Webb D, Tarlton D. BMJ 2019; 365 :l1648.

Actions needed to prevent noncommunicable diseases and improve mental health

Banatvala N, Akselrod S, Webb D, Sladden T, Hipgrave D, Schneidman M. Bull World Health Organ 2019:97;75-75A.

2018

Addressing NCDs: A unifying agenda for sustainable development

Collins T, Mikkelsen B, Adams J, Chestnov O, Evans T, Feigl A, Nugent R, Pablos-Mendez A, Srivanichakorn S, Webb D. Glob Public Health. 2018;13:1152-1157.

Commercial influence in control of non-communicable diseases

Whitaker K, Webb D, Linou N. BMJ. 2018;360:k110.

Pollution and non-communicable disease: time to end the neglect

Fuller R,  Rahona E, Fisher S, Caravanos J, Webb D, Kass D, Landrigan JP. Lancet Planet Health. 2018;2:e96-e98.

Sugar, tobacco, and alcohol taxes to achieve the SDGs

Sugar, Tobacco, and Alcohol Taxes (STAX) Group. 2018. Lancet: 391; 2400-1.

2016

Building leadership capacity to prevent and control noncommunicable diseases: evaluation of an international short-term training program for program managers from low- and middle-income countries

Erzse A, Bovet P, Paccaud F, Chestnov O, Banatvala N. Int J Public Health. 2016. DOI 10.1007/s00038-016-0913.

2015

Screening for cardiovascular disease risk and subsequent management in low- and middle-income countries: challenges and opportunities

Bovet P, Chiolero A, Paccaud F, Banatvala N. Public Health Reviews. 2015:36;13-28.

2014

Global Health Threats of the 21st Century: Noncommunicable Diseases and Mental Disorders

Chisholm D, Banatvala N. Finance and Development 2014: 51:18-19.

2013

Improvement in responsiveness of health systems to non-communicable diseases

Atun R, Jaffar S, Nishtar S, Knaul F, Barreto M, Nyirenda M, Banatvala N, Piot P. Lancet. 2013; 381:690-7.